CHEBI:44185 - methotrexate

ChEBI IDCHEBI:44185
ChEBI Namemethotrexate
Stars
Secondary ChEBI IDsCHEBI:6837, CHEBI:44183
Last Modified22 February 2017
DownloadsMolfile
FormulaC20H22N8O5
Net Charge0
Average Mass454.447
Monoisotopic Mass454.17132
SMILESCN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1
InChIInChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1
InChIKeyFBOZXECLQNJBKD-ZDUSSCGKSA-N
Wikipedia
Roles Classification
Chemical Role:
Bronsted acid  A molecular entity capable of donating a hydron to an acceptor (Brønsted base).
Biological Roles:
DNA synthesis inhibitor  Any substance that inhibits the synthesis of DNA.
immunosuppressive agent  An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
antimetabolite  A substance which is structurally similar to a metabolite but which competes with it or replaces it, and so prevents or reduces its normal utilization.
EC 1.5.1.3 (dihydrofolate reductase) inhibitor  An EC 1.5.1.* (oxidoreductase acting on donor CH-NH group, NAD+ or NADP+ as acceptor) inhibitor that interferes with the action of dihydrofolate reductase (EC 1.5.1.3).
Applications:
dermatologic drug  A drug used to treat or prevent skin disorders or for the routine care of skin.
antineoplastic agent  A substance that inhibits or prevents the proliferation of neoplasms.
immunosuppressive agent  An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response.
abortifacient  A chemical substance that interrupts pregnancy after implantation.
antirheumatic drug  A drug used to treat rheumatoid arthritis.
ChEBI Ontology
Outgoing Relation(s)
methotrexate (CHEBI:44185) has functional parent L-glutamic acid (CHEBI:16015)
methotrexate (CHEBI:44185) has role abortifacient (CHEBI:50691)
methotrexate (CHEBI:44185) has role antimetabolite (CHEBI:35221)
methotrexate (CHEBI:44185) has role antineoplastic agent (CHEBI:35610)
methotrexate (CHEBI:44185) has role antirheumatic drug (CHEBI:35842)
methotrexate (CHEBI:44185) has role dermatologic drug (CHEBI:50177)
methotrexate (CHEBI:44185) has role DNA synthesis inhibitor (CHEBI:59517)
methotrexate (CHEBI:44185) has role EC 1.5.1.3 (dihydrofolate reductase) inhibitor (CHEBI:50683)
methotrexate (CHEBI:44185) has role immunosuppressive agent (CHEBI:35705)
methotrexate (CHEBI:44185) is a dicarboxylic acid (CHEBI:35692)
methotrexate (CHEBI:44185) is a monocarboxylic acid amide (CHEBI:29347)
methotrexate (CHEBI:44185) is a pteridines (CHEBI:26373)
methotrexate (CHEBI:44185) is conjugate acid of methotrexate(1−) (CHEBI:50680)
Incoming Relation(s)
methotrexate(1−) (CHEBI:50680) is conjugate base of methotrexate (CHEBI:44185)
IUPAC Name 
N-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)-L-glutamic acid
INNs  Source
methotrexateKEGG DRUG
methotrexatumChemIDplus
metotrexatoChemIDplus
Synonyms  Source
MethotrexateKEGG COMPOUND
N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acidNIST Chemistry WebBook
4-amino-N10-methylpteroylglutamic acidNIST Chemistry WebBook
METHOTREXATEPDBeChem
MTXChemIDplus
4-amino-10-methylfolic acidChemIDplus
Brand Names  Source
EmtexateDrugBank
LedertrexateDrugBank
RheumatrexDrugBank
TrexallDrugBank
Manual XrefsDatabases
C01937KEGG COMPOUND
MTXPDBeChem
D00142KEGG DRUG
DB00563DrugBank
US2512572Patent
MethotrexateWikipedia
LSM-5690LINCS
1751DrugCentral
Registry NumbersSources
Beilstein:70669Beilstein
CAS:59-05-2KEGG COMPOUND
CAS:59-05-2ChemIDplus
CAS:59-05-2NIST Chemistry WebBook